TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24740588
Drug: 750 ml
Normalized name: ALCOHOL 750 mL in 1 L TOPICAL GEL
Approvals — FDA: no, EMA: no, PMDA: no
Description: 750 ml of fresh coffee brew
Study: 24740588
Drug: 750 ml
Normalized name: ALCOHOL 750 mL in 1 L TOPICAL GEL
Approvals — FDA: no, EMA: no, PMDA: no
Description: 750 ml of water
Study: 15084240
Drug: Red clover-derived
Approvals — FDA: no, EMA: no, PMDA: no
Description: Red clover-derived isoflavone supplement
Study: 15298795
Drug: Diphenhydramine (25
Approvals — FDA: no, EMA: no, PMDA: no
Description: Diphenhydramine (25 mg)
Study: 24760656
Drug: OLM/AML/HCTZ 40/5/25
Approvals — FDA: no, EMA: no, PMDA: no
Description: OLM/AML/HCTZ 40/5/25 mg
Study: 26176708
Drug: OLM/AML/HCTZ 40/10/12.5
Approvals — FDA: no, EMA: no, PMDA: no
Description: OLM/AML/HCTZ 40/10/12.5 mg
Study: 26176708
Drug: OLM/AML/HCTZ 40/10/25
Approvals — FDA: no, EMA: no, PMDA: no
Description: OLM/AML/HCTZ 40/10/25 mg
Study: 18446025
Drug: Sugar-free gum
Normalized name: Diabetic Multivitamin Sugar-Free Gummies
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sugar-free gum containing 54 mg CPP-ACP
Study: 8958892
Drug: Salmeterol 50
Normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
Approvals — FDA: no, EMA: no, PMDA: no
Description: Salmeterol 50 micrograms twice daily (n = 22)
Study: 3004088
Drug: 0.20 mg
Normalized name: FENTANYL 10.20 mg in 1 [USP'U] TRANSDERMAL PATCH [Fentanyl]
Approvals — FDA: no, EMA: no, PMDA: no
Description: 0.20 mg kg‐1 etomidate
Study: 11701073
Drug: Isotonic sodium
Normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
Approvals — FDA: no, EMA: no, PMDA: no
Description: Isotonic sodium chloride solution (ISCS)
Study: 17478034
Drug: Propionyl L‐carnitine
Approvals — FDA: no, EMA: no, PMDA: no
Description: Propionyl L‐carnitine (PLC) alone (2 g/d)
Study: 17478034
Drug: Propionyl L‐carnitine
Approvals — FDA: no, EMA: no, PMDA: no
Description: Propionyl L‐carnitine (PLC) plus sildenafil (50 mg/d twice weekly)
Study: 15620433
Drug: rosiglitazone (4
Approvals — FDA: no, EMA: no, PMDA: no
Description: rosiglitazone (4 mg per day for 12 weeks)
Study: 10623334
Drug: Lower procaterol
Normalized name: procaterol
DrugBank: Procaterol (DB01366)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Lower procaterol dose via large-volume spacer
Study: 31789898
Drug: Ropivacaine 10
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ropivacaine 10 mg in 2.5 ml saline (4 mg/ml)
Study: 31789898
Drug: Ropivacaine 10
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ropivacaine 10 mg in 5 ml saline (2 mg/ml)
Study: 31789898
Drug: Ropivacaine 10
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ropivacaine 10 mg in 10 ml saline (1 mg/ml)
Study: 31789898
Drug: Ropivacaine 10
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ropivacaine 10 mg in 20 ml saline (0.5 mg/ml)
Study: 25681448
Drug: Delayed-release dimethyl
Normalized name: dimethyl fumarate Delayed Release Oral Capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: Delayed-release dimethyl fumarate (DMF) 240 mg twice daily (BID)
Study: 25681448
Drug: Subcutaneous glatiramer
Normalized name: Glatiramer
DrugBank: Glatiramer (DB05259)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Subcutaneous glatiramer acetate 20 mg once daily (active reference comparator)
Study: 21277255
Drug: ramelteon 4
Normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: ramelteon 4 or 8 mg, titrated up to 16 mg if necessary for 24 weeks
Study: 28885365
Drug: Neuromuscular electrical
Normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Neuromuscular electrical stimulation plus EMG-biofeedback therapy
Study: 23266209
Drug: High-dose DHA
Approvals — FDA: no, EMA: no, PMDA: no
Description: High-dose DHA (100 mg/kg/day for the first month and 1g per day thereafter for 12 months)
Study: 16680932
Drug: Fexofenadine hydrochloride
Normalized name: Fexofenadine Hydrochloride
DrugBank: Fexofenadine (DB00950)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Fexofenadine hydrochloride (60 mg) pretreatment 2 hours before immunization injection
Study: 8169755
Drug: High-dose RSV
Approvals — FDA: no, EMA: no, PMDA: no
Description: High-dose RSV immune globulin (750 mg/kg, 15 ml/kg)
Study: 8169755
Drug: Low-dose RSV
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose RSV immune globulin (150 mg/kg, 3 ml/kg)
Study: 8169755
Drug: High-dose RSV
Approvals — FDA: no, EMA: no, PMDA: no
Description: High-dose RSV immune globulin
Study: 913294
Drug: Propranolol (160
Approvals — FDA: no, EMA: no, PMDA: no
Description: Propranolol (160 mg/d)
Study: 3275861
Drug: Placebo (500
Approvals — FDA: no, EMA: no, PMDA: no
Description: Placebo (500 mg lactose/d)
Study: 3275861
Drug: Terbutaline (15
Approvals — FDA: no, EMA: no, PMDA: no
Description: Terbutaline (15 mg/d)
Study: 24135845
Drug: Dextroamphetamine (AMP)
DrugBank: Dextroamphetamine (DB01576)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dextroamphetamine (AMP) 10 mg
Study: 24135845
Drug: Dextroamphetamine (AMP)
DrugBank: Dextroamphetamine (DB01576)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dextroamphetamine (AMP) 20 mg